ArticleDementia and geriatric cognitive disorders extra

A 24-Week, Randomized, Controlled Study to Evaluate the Tolerability, Safety and Efficacy of 2 Different Titration Schemes of the Rivastigmine Patch in Japanese Patients with Mild to Moderate Alzheimer's Disease.

Yu Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.